Production (Stage)
Aethlon Medical, Inc.
AEMD
$1.18
-$0.045-3.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.07% | -13.25% | -7.28% | -8.68% | 1.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.07% | -13.25% | -7.28% | -8.68% | 1.31% |
| Operating Income | 26.07% | 9.01% | 2.81% | 4.45% | -6.20% |
| Income Before Tax | -9.66% | 21.97% | 3.12% | 7.33% | -1.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.66% | 21.97% | 3.12% | 7.33% | -1.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.66% | 21.97% | 3.12% | 7.33% | -1.48% |
| EBIT | 26.07% | 9.01% | 2.81% | 4.45% | -6.20% |
| EBITDA | 26.68% | 9.19% | 2.98% | 5.01% | -5.31% |
| EPS Basic | 77.39% | 68.20% | 41.72% | 29.68% | 19.15% |
| Normalized Basic EPS | 77.33% | 58.72% | 42.00% | 29.04% | 18.45% |
| EPS Diluted | 77.39% | 68.20% | 41.72% | 29.68% | 19.15% |
| Normalized Diluted EPS | 77.33% | 58.72% | 42.00% | 29.04% | 18.45% |
| Average Basic Shares Outstanding | 396.45% | 290.51% | 179.21% | 65.82% | 22.42% |
| Average Diluted Shares Outstanding | 396.45% | 290.51% | 179.21% | 65.82% | 22.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |